We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+14.75%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$2.53B
AUM Growth
+$83.8M
Cap. Flow
-$119M
Cap. Flow %
-4.7%
Top 10 Hldgs %
15.65%
Holding
459
New
168
Increased
55
Reduced
55
Closed
164

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$33.2M
2
GD icon
General Dynamics
GD
+$29.9M
3
RRC icon
Range Resources
RRC
+$28.6M
4
PF
Pinnacle Foods, Inc.
PF
+$25.1M
5
DHR icon
Danaher
DHR
+$23.4M

Sector Composition

Rank Sector Weight
1 Industrials 16.3%
2 Healthcare 12.56%
3 Financials 10.78%
4 Energy 9.71%
5 Consumer Discretionary 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRTX
276
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$832K 0.03%
+50,000
New +$855K
BLMN icon
277
Bloomin' Brands
BLMN
$938M
$818K 0.03%
+34,057
New +$822K
ATHM icon
278
Autohome
ATHM
$2.62B
$732K 0.03%
+20,000
New +$608K
KFN
279
DELISTED
KKR FINANCIAL HOLDINGS LLC COM
KFN
$689K 0.03%
+56,535
New +$580K
NMBL
280
DELISTED
Nimble Storage, Inc.
NMBL
$680K 0.03%
+15,000
New +$570K
DRTX
281
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
$640K 0.03%
50,000
-50,000
-50% -$524K
VJET
282
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
$625K 0.02%
+3,164
New +$631K
TBRA
283
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$553K 0.02%
12,891
+5,556
+76% +$261K
BLUE
284
DELISTED
bluebird bio
BLUE
$486K 0.02%
1,787
-1,301
-42% -$364K
HRTX icon
285
Heron Therapeutics
HRTX
$92.9M
$445K 0.02%
+50,000
New +$445K
RMGN
286
DELISTED
RMG Networks Holding Corporation
RMGN
$436K 0.02%
22,450
-2,550
-10% -$63.4K
HNSN
287
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$407K 0.02%
23,541
+6,517
+38% +$121K
CCIX
288
DELISTED
COLEMAN CABLE IN COM
CCIX
$383K 0.02%
+14,600
New +$338K
GEVO icon
289
Gevo
GEVO
$382M
$358K 0.01%
+42
New +$402K
HOG icon
290
Harley-Davidson
HOG
$2.71B
$346K 0.01%
+5,000
New +$331K
PGEN icon
291
Precigen
PGEN
$2.59B
$311K 0.01%
13,690
-7,551
-36% -$153K
ANTH
292
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$223K 0.01%
9,100
MTGE
293
DELISTED
MTGE Investment Corp. Common Stock
MTGE
$205K 0.01%
+11,725
New +$225K
VELT
294
DELISTED
VELTI PLC, ST HELIER ORDINARY SHARES (JERSEY)
VELT
$76K ﹤0.01%
1,365,208
AAPL icon
295
CALL
Apple
AAPL
$4.57T
-1,237,600
Closed -$21.1M
AAPL icon
296
Apple
AAPL
$4.57T
-157,192
Closed -$2.68M
ABR icon
297
Arbor Realty Trust
ABR
$998M
-95,077
Closed -$645K
ACHC icon
298
Acadia Healthcare
ACHC
$2.94B
-28,954
Closed -$1.14M
ADM icon
299
Archer Daniels Midland
ADM
$36.9B
-120,700
Closed -$4.45M
AMGN icon
300
Amgen
AMGN
$222B
-25,000
Closed -$2.8M

Similar funds

Alyeska Investment Group's Q4 2013 Portfolio in Review

As of Q4 2013, Alyeska Investment Group held 459 positions worth $2.53B, up 3.4% from $2.45B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Alyeska Investment Group withdrew a net $119M in Q4 2013, closing 164 positions and reducing 55 holdings. Its most notable exit was Eaton, an estimated $27.5M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Alyeska Investment Group opened a new position in 3M worth $36.5M.

  • Alyeska Investment Group's largest Q4 2013 buy was 3M: 311,278 shares worth $36.5M.
  • Alyeska Investment Group added most to Range Resources in Q4 2013, an estimated $28.6M increase.
  • Alyeska Investment Group's biggest Q4 2013 reduction was Hartford Financial Services, cutting an estimated $25.5M.
  • Alyeska Investment Group fully exited Eaton in Q4 2013, selling an estimated $27.5M.
  • Alyeska Investment Group's ten largest holdings make up 16% of its $2.53B portfolio in Q4 2013.
  • Alyeska Investment Group opened 168 new positions and closed 164 in Q4 2013.
  • Alyeska Investment Group's portfolio value rose 3.4% quarter-over-quarter to $2.53B.

Based on Alyeska Investment Group's 13F filing for Q4 2013, filed 14 Feb 2014.